Evidence map›Paper›PMID 32575924›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Solid Plasmonic Substrates for Breast Cancer Detection by Means of SERS Analysis of Blood Plasma.

Gabriela Fabiola Știufiuc, Valentin Toma, Mihail Buse, Radu Mărginean, Gabriela Morar-Bolba, Bogdan Culic, Romulus Tetean, Nicolae Leopold, Ioana Pavel, Constantin Mihai Lucaciu and 1 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gabriela Fabiola ȘtiufiucFaculty of Physics, "Babeș-Bolyai" University, M. Kogalniceanu 1, 400084 Cluj-Napoca, Romania.
Valentin TomaMedFuture Research Center for Advance Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, L. Pasteur 4-6, 400349 Cluj-Napoca, Romania.
Mihail BuseMedFuture Research Center for Advance Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, L. Pasteur 4-6, 400349 Cluj-Napoca, Romania.
Radu MărgineanMedFuture Research Center for Advance Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, L. Pasteur 4-6, 400349 Cluj-Napoca, Romania.
Gabriela Morar-BolbaDepartment of Senology, The Oncology Institute "Prof. Dr. Ion Chiricuta", 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
Bogdan CulicDepartment of Dental Propedeutics and Esthetics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 8 V. Babes Street, 400012 Cluj-Napoca, Romania.
Romulus TeteanFaculty of Physics, "Babeș-Bolyai" University, M. Kogalniceanu 1, 400084 Cluj-Napoca, Romania.
Nicolae LeopoldFaculty of Physics, "Babeș-Bolyai" University, M. Kogalniceanu 1, 400084 Cluj-Napoca, Romania.ORCID 0000-0002-2174-8064
Ioana PavelDepartment of Chemistry, Wright State University, 3640 Colonel Glenn Hwy., Dayton, OH 45435-0001, USA.
Constantin Mihai LucaciuDepartment of Pharmaceutical Physics-Biophysics, "Iuliu Hațieganu" University of Medicine and Pharmacy, L. Pasteur 6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-9385-3568
Rareș Ionuț ȘtiufiucMedFuture Research Center for Advance Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, L. Pasteur 4-6, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-6769-1545

Funding

Competitiveness Operational Program 2014-2020 POC-A1-A1.1.4-E-2015 P_37_765Romanian National Authority for Scientific Research, CNCSIS-UEFISCDI PN-III-P4-ID-PCCF-2016-0112
6 · The paper itself

Abstract

Surface enhanced Raman spectroscopy (SERS) represents a promising technique in providing specific molecular information that could have a major impact in biomedical applications, such as early cancer detection. SERS requires the presence of a suitable plasmonic substrate that can generate enhanced and reproducible diagnostic relevant spectra. In this paper, we propose a new approach for the synthesis of such a substrate, by using concentrated silver nanoparticles purified using the Tangential Flow Filtration method. The capacity of our substrates to generate reproducible and enhanced Raman signals, in a manner that can allow cancer detection by means of Multivariate Analysis (MVA) of Surface Enhanced Raman (SER) spectra, has been tested on blood plasma samples collected from 35 healthy donors and 29 breast cancer patients. All the spectra were analyzed by a combined Principal Component-Linear Discriminant Analysis. Our results facilitated the discrimination between healthy donors and breast cancer patients with 90% sensitivity, 89% specificity and 89% accuracy. This is a direct consequence of substrates' ability to generate diagnostic relevant spectral information by performing SERS measurements on pristine blood plasma samples. Our results suggest that this type of solid substrate could be employed for the detection of other types of cancer or other diseases by means of MVA-SERS procedure.

Indexed as

biofluidsMVA-SERS based cancer detectionSERSsolid plasmonic substrates

Identifiers

PMID32575924
PMCPMC7353077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.